Effect of propofol and remifentanil on surgical plethysmography index during general anesthesia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044018

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-18

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group P:Propofol

Group R:Remifentanil

Group PR:Propofol and Remifentanil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing surgery under elective general anesthesia, ASA grade I or II, NYHA grade I or II, age 18 to 65 years old, BMI 18 to 30 kg/m2.

Exclusion criteria

Exclusion criteria: History of diabetes, arrhythmia, nervous system and endocrine diseases (thyroid or adrenal glands), preoperative medications that affect the autonomic nervous system (including ß-receptor antagonists, atropine and cardiac glycosides), general anesthetics and local anesthetics history of allergies, drug, alcohol abuse history.

Design outcomes

Primary

Measure	Time frame
surgical pleth index;	—

Secondary

Measure	Time frame
BIS;HR;BP;	—

Countries

China

Contacts

Public ContactZhaoxin Zheng

Zhongshan Hospital Affiliated to Xiamen University

1083928884@qq.com+86 18060995056

Outcome results